Waltham, MA based Alere Inc. ALR, a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology ...

WALTHAM, Mass., January 4, 2017 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its forensic toxicology division, Alere Forensics at Redwood Toxicology Laboratory, ...

NEW YORK, May 21 (Reuters) - An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much ...

The global Toxicology Drug Screening Market Revenue is expected to generate US$ 71,901.8 million by 2032, up from US$ 23,888.5 million in 2022, at a 10.5% CAGR over the forecast period. Toxicology ...

A publicly-traded global diagnostic device and service provider based in Waltham, Mass., has acquired US Diagnostics (USD) of Huntsville for $60 million in cash. Alere, working with Founders ...

WALTHAM, Mass., July 16, 2015 /PRNewswire/ — Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today two transactions that further strengthen the Company’s focus on its core ...

Alere itself toyed with the idea of selling the unit in the past. Chief Executive Ron Zwanziger said at the JPMorgan healthcare conference in January 2011 that the company had a "fair amount of debt" ...

Publicly traded Alere Inc. is paying up to $340 million to buy eScreen Inc., a technology company that specializes in toxicology screening and employee health products and services. The purchase price ...

When Alere ($ALR) CEO Namal Nawana took the reins of the company last year, he pledged he would get things back on track with a series of cost-cutting measures and by ...

NEW YORK (Reuters) - An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much as $2.5 ...